148 related articles for article (PubMed ID: 9777656)
1. Analgesic effect of mofezolac, a non-steroidal anti-inflammatory drug, against phenylquinone-induced acute pain in mice.
Goto K; Ochi H; Yasunaga Y; Matsuyuki H; Imayoshi T; Kusuhara H; Okumoto T
Prostaglandins Other Lipid Mediat; 1998 Jul; 56(4):245-54. PubMed ID: 9777656
[TBL] [Abstract][Full Text] [Related]
2. Involvement of prostaglandins produced by cyclooxygenase-1 in murine visceronociception induced by phenylquinone.
Kusuhara H; Matsuyuki H; Okumoto T
Prostaglandins Other Lipid Mediat; 1998 Jan; 55(1):43-9. PubMed ID: 9661217
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological profile of mofezolac, a new non-steroidal analgesic anti-inflammatory drug].
Ono N; Yamamoto N; Sunami A; Yamasaki Y; Miyake H
Nihon Yakurigaku Zasshi; 1990 Feb; 95(2):63-81. PubMed ID: 2109726
[TBL] [Abstract][Full Text] [Related]
4. Zaltoprofen, a non-steroidal anti-inflammatory drug, inhibits bradykinin-induced pain responses without blocking bradykinin receptors.
Hirate K; Uchida A; Ogawa Y; Arai T; Yoda K
Neurosci Res; 2006 Apr; 54(4):288-94. PubMed ID: 16473424
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
6. An attempt to chemically state the cross-talk between monomers of COX homodimers by double/hybrid inhibitors mofezolac-spacer-mofezolac and mofezolac-spacer-arachidonic acid.
Perrone MG; Miciaccia M; Vitale P; Ferorelli S; Araújo CDCB; de Almeida GS; Souza Domingos TF; da Silva LCRP; de Pádula M; Cabral LM; Sathler PC; Bonaccorso C; Fortuna CG; Scilimati A
Eur J Med Chem; 2021 Jan; 209():112919. PubMed ID: 33129592
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptotic DNA fragmentation by nonsteroidal anti-inflammatory drugs in cultured rat gastric mucosal cells.
Kusuhara H; Matsuyuki H; Matsuura M; Imayoshi T; Okumoto T; Matsui H
Eur J Pharmacol; 1998 Nov; 360(2-3):273-80. PubMed ID: 9851595
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and analgesic/anti-inflammatory evaluation of novel diarylthiazole and diarylimidazole derivatives towards selective COX-1 inhibitors with better gastric profile.
Abdelazeem AH; El-Saadi MT; Safi El-Din AG; Omar HA; El-Moghazy SM
Bioorg Med Chem; 2017 Jan; 25(2):665-676. PubMed ID: 27916468
[TBL] [Abstract][Full Text] [Related]
9. Amide derivatives of [6-(5-methyl-3-phenylpyrazole-1-yl)-3(2H)-pyridazinone-2-yl]acetic acids as potential analgesic and anti-inflammatory compounds.
Banoglu E; Akoğlu C; Unlü S; Küpeli E; Yeşilada E; Sahin MF
Arch Pharm (Weinheim); 2004 Jan; 337(1):7-14. PubMed ID: 14760622
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory and analgesic effects of a novel pyrazole derivative, FR140423.
Ochi T; Jobo-Magari K; Yonezawa A; Matsumori K; Fujii T
Eur J Pharmacol; 1999 Jan; 365(2-3):259-66. PubMed ID: 9988110
[TBL] [Abstract][Full Text] [Related]
12. A further pocket or conformational plasticity by mapping COX-1 catalytic site through modified-mofezolac structure-inhibitory activity relationships and their antiplatelet behavior.
Solidoro R; Miciaccia M; Bonaccorso C; Fortuna CG; Armenise D; Centonze A; Ferorelli S; Vitale P; Rodrigues P; Guimarães R; de Oliveira A; da Paz M; Rangel L; Sathler PC; Altomare A; Perrone MG; Scilimati A
Eur J Med Chem; 2024 Feb; 266():116135. PubMed ID: 38219659
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat.
Jett MF; Ramesha CS; Brown CD; Chiu S; Emmett C; Voronin T; Sun T; O'Yang C; Hunter JC; Eglen RM; Johnson RM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1288-97. PubMed ID: 10027870
[TBL] [Abstract][Full Text] [Related]
14. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
15. Inducible cyclooxygenase may have anti-inflammatory properties.
Gilroy DW; Colville-Nash PR; Willis D; Chivers J; Paul-Clark MJ; Willoughby DA
Nat Med; 1999 Jun; 5(6):698-701. PubMed ID: 10371510
[TBL] [Abstract][Full Text] [Related]
16. [New NSAIDS: COX-1, COX-2, what about them?].
Peretz A
Rev Med Brux; 1998 Sep; 19(4):A399-402. PubMed ID: 9805982
[TBL] [Abstract][Full Text] [Related]
17. Are COX-2 inhibitors as effective as conventional NSAIDs in acute pain states?
Bannwarth B
Arch Intern Med; 2001 Jan; 161(1):127-8. PubMed ID: 11146712
[No Abstract] [Full Text] [Related]
18. Nonsteroidal anti-inflammatory drugs, acetaminophen, cyclooxygenase 2, and fever.
Simmons DL; Wagner D; Westover K
Clin Infect Dis; 2000 Oct; 31 Suppl 5():S211-8. PubMed ID: 11113025
[TBL] [Abstract][Full Text] [Related]
19. Effects of non-steroidal anti-inflammatory drugs on prostaglandin E2 production by cyclooxygenase-2 from endogenous and exogenous arachidonic acid in rat peritoneal macrophages stimulated with lipopolysaccharide.
Nakatsugi S; Sugimoto N; Furukawa M
Prostaglandins Leukot Essent Fatty Acids; 1996 Dec; 55(6):451-7. PubMed ID: 9014225
[TBL] [Abstract][Full Text] [Related]
20. The analgesic effect profile of FR122047, a selective cyclooxygenase-1 inhibitor, in chemical nociceptive models.
Ochi T; Motoyama Y; Goto T
Eur J Pharmacol; 2000 Mar; 391(1-2):49-54. PubMed ID: 10720634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
